Dec. 7 Quick Takes: Freenome raises $300M series D

Freenome Inc. has raised a $300 million series D round, led by Perceptive Advisors and RA Capital Management. The company, which is developing early detection methods for cancer, has now raised $800 million since it was co-founded by Riley Ennis in 2014. Funds will be used to advance the company’s colorectal cancer screening test and expand its multi-omics platform.

With a £40 million ($53 million) series A investment from Apple Tree Partners in hand, newco Adendra Therapeutics Ltd. will develop cancer and autoimmune disease treatments based on Caetano Reis e Sousa’s research into the regulation of adaptive immune responses by dendritic cells. Co-founded by ATP entrepreneur-in-residence Raj Mehta, Adendra is ATP’s first U.K. portfolio company. Sousa is a senior group leader at London’s  Francis Crick Institute and a professor of immunology at Imperial College...